Sonoma Pharmaceuticals (SNOA) Expected to Announce Quarterly Earnings on Monday

Posted by Brian Himes on Nov 9th, 2026

Sonoma Pharmaceuticals (NASDAQ:SNOA – Get Free Report) will likely be posting its resultson Monday, November 16th. Analysts expect Sonoma Pharmaceuticals to post earnings of ($0.10) per share and revenue of $5.29 million for the quarter.

Sonoma Pharmaceuticals (NASDAQ:SNOA – Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of ($0.30) by $0.32. Sonoma Pharmaceuticals had a negative net margin of 10.33% and a negative return on equity of 21.41%. The firm had revenue of $6.41 million for the quarter, compared to the consensus estimate of $4.99 million.

Sonoma Pharmaceuticals Stock Performance

SNOA stock opened at $1.11 on Monday. Sonoma Pharmaceuticals has a 52 week low of $0.85 and a 52 week high of $3.95. The company has a market capitalization of $5.32 million, a price-to-earnings ratio of -0.91 and a beta of 1.31. The firm’s 50-day moving average is $1.22 and its two-hundred day moving average is $1.67.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings lowered shares of Sonoma Pharmaceuticals from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday, August 21st. One analyst has rated the stock with a Sell rating. According to MarketBeat, the stock currently has an average rating of “Sell”.

Get Our Latest Analysis on Sonoma Pharmaceuticals

Sonoma Pharmaceuticals Company Profile

(Get Free Report)

Sonoma Pharmaceuticals, Inc is a specialty pharmaceutical company focused on developing, manufacturing and commercializing non-antibiotic and non-steroidal products for human and animal health. Its products are designed for applications including dermatology, wound care, eye care and veterinary treatment.

The company’s product portfolio is based primarily on Microcyn technology, a stabilized hypochlorous acid solution intended to cleanse, debride and manage wounds and various skin conditions.